AAAAAA
Results:
1-25
|
Results: 25
Authors:
Loveday, C
Citation: C. Loveday, Nucleoside reverse transcriptase inhibitor resistance, J ACQ IMM D, 26, 2001, pp. S10-S24
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Mocroft, A
Youle, M
Moore, A
Sabin, CA
Madge, S
Lepri, AC
Tyrer, M
Chaloner, C
Wilson, D
Loveday, C
Johnson, MA
Phillips, AN
Citation: A. Mocroft et al., Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre, AIDS, 15(2), 2001, pp. 185-194
Authors:
Devereux, HL
Emery, VC
Johnson, MA
Loveday, C
Citation: Hl. Devereux et al., Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations, J MED VIROL, 65(2), 2001, pp. 218-224
Authors:
Hoggard, PG
Lloyd, J
Khoo, SH
Barry, MG
Dann, L
Gibbons, SE
Wilkins, EG
Loveday, C
Back, DJ
Citation: Pg. Hoggard et al., Zidovudine phosphorylation determined sequentially over 12 months in humanimmunodeficiency virus-infected patients with or without previous exposureto antiretroviral agents, ANTIM AG CH, 45(3), 2001, pp. 976-980
Authors:
Sabin, CA
Lepri, AC
Devereux, H
Phillips, AN
Loveday, C
Lee, CA
Citation: Ca. Sabin et al., Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia, J INFEC DIS, 184(4), 2001, pp. 511-514
Authors:
Sabin, CA
Devereux, H
Phillips, AN
Hill, A
Janossy, G
Lee, CA
Loveday, C
Citation: Ca. Sabin et al., Course of viral load throughout HIV-1 infection, J ACQ IMM D, 23(2), 2000, pp. 172-177
Authors:
Devereux, HL
Loveday, C
Youle, M
Sabin, CA
Burke, A
Johnson, M
Citation: Hl. Devereux et al., Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients, AIDS RES H, 16(11), 2000, pp. 1025-1030
Authors:
Sabin, CA
Yee, TT
Devereux, H
Griffioen, A
Loveday, C
Phillips, AN
Lee, CA
Citation: Ca. Sabin et al., Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1001-1007
Authors:
Dean, GL
Fisher, M
Loveday, C
Citation: Gl. Dean et al., HIV drug-resistance testing on archived samples to help current clinical decisions, AIDS, 14(2), 2000, pp. 208-209
Authors:
Youle, M
Janossy, G
Turnbull, W
Tilling, R
Loveday, C
Mocroft, A
Tyrer, M
Madge, S
Wilson, D
Dykhoff, A
Johnson, M
Phillips, AN
Citation: M. Youle et al., Changes in CD4 lymphocyte counts after interruption of therapy in patientswith viral failure on protease inhibitor-containing regimens, AIDS, 14(12), 2000, pp. 1717-1720
Authors:
Mocroft, A
Devereux, H
Kinloch-de-Loes, S
Wilson, D
Madge, S
Youle, M
Tyrer, M
Loveday, C
Phillips, AN
Johnson, MA
Citation: A. Mocroft et al., Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population, AIDS, 14(11), 2000, pp. 1545-1552
Authors:
Dunn, DT
Simonds, RJ
Bulterys, M
Kalish, LA
Moye, J
de Maria, A
Kind, C
Rudin, C
Denamur, E
Krivine, A
Loveday, C
Newell, ML
Citation: Dt. Dunn et al., Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples, AIDS, 14(10), 2000, pp. 1421-1428
Authors:
Hirsch, MS
Brun-Vezinet, F
D'Aquila, RT
Hammer, SM
Johnson, VA
Kuritzkes, DR
Loveday, C
Mellors, JW
Clotet, B
Conway, B
Demeter, LM
Vella, S
Jacobsen, DM
Richman, DD
Citation: Ms. Hirsch et al., Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel, J AM MED A, 283(18), 2000, pp. 2417-2426
Authors:
Sabin, CA
Devereux, HL
Clewley, G
Emery, VC
Phillips, AN
Loveday, C
Lee, CA
Griffiths, PD
Citation: Ca. Sabin et al., Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNAlevels in individuals with hemophilia, J INFEC DIS, 181(5), 2000, pp. 1800-1803
Authors:
Devereux, HL
Loveday, C
Youle, M
Sabin, CA
Burke, A
Johnson, MA
Citation: Hl. Devereux et al., Reduction in human immunodeficiency virus type 1 mutations associated withdrug resistance after initiating new therapeutic regimens in pretreated patients, J INFEC DIS, 181(5), 2000, pp. 1804-1807
Authors:
Loveday, C
Dunn, D
McCormack, S
Babiker, A
Citation: C. Loveday et al., The use of HIV resistance assays - random or randomised?, SEX TRANS I, 75(3), 1999, pp. 140-141
Authors:
Aboulker, JP
Babiker, AG
Flandre, P
Gazzard, B
Loveday, C
Nunn, AJ
Goudsmit, J
Huraux, JM
van der Noorda, J
Weiss, R
Boucher, C
Schurrman, R
Brun-Vezinet, F
Descamps, D
Jeffries, D
Tedder, R
Weber, J
Darbyshire, JH
Reiss, P
Weverling, G
Citation: Jp. Aboulker et al., An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome, AIDS, 13(5), 1999, pp. 565-573
Authors:
Loveday, C
Devereux, H
Huckett, L
Johnson, M
Citation: C. Loveday et al., High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient population, AIDS, 13(5), 1999, pp. 627-628
Authors:
Devereux, HL
Youle, M
Johnson, MA
Loveday, C
Citation: Hl. Devereux et al., Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy, AIDS, 13(18), 1999, pp. F123-F127
Authors:
Babiker, AG
Darbyshire, JH
Gazzard, BG
Hooker, MH
Kitchen, V
Newberry, A
Peto, TE
Tedder, R
Weber, J
Breckenridge, A
Back, D
Blatchford, N
Gartland, M
Jeffries, D
Johnson, M
Plummer, K
Wills, B
Loveday, C
Weller, IVD
Withnall, R
Citation: Ag. Babiker et al., A randomized trial comparing regimens of four reverse transcriptase inhibitors given together or cyclically in HIV-1 infection - The Quattro Trial, AIDS, 13(16), 1999, pp. 2209-2217
Authors:
Phillips, AN
McLean, AR
Loveday, C
Tyrer, M
Bofill, M
Devereux, H
Madge, S
Dykoff, A
Drinkwater, A
Burke, A
Huckett, L
Janossy, G
Johnson, MA
Citation: An. Phillips et al., In vivo HIV-1 replicative capacity in early and advanced infection, AIDS, 13(1), 1999, pp. 67-73
Authors:
Devereux, H
Loveday, C
Burke, A
Dann, L
Johnson, M
Phillips, A
Citation: H. Devereux et al., The prevalence of non-B subtype HIV-1 in a London HIV/AIDS outpatient clinic, AIDS, 13(1), 1999, pp. 142-142
Authors:
King, DJS
Amjadi, P
Tilling, R
Kinloch-de-Loes, S
Loveday, C
Johnson, MA
Janossy, G
Tarragona, A
Gotch, F
Larsson-Sciard, EL
Citation: Djs. King et al., 'Naive' and 'memory' CD4(+) T-cells and T-cell receptor (TCR) V beta repertoire dynamics are independent of the levels of viremia following HIV seroconversion, IMMUNOL LET, 66(1-3), 1999, pp. 199-206
Authors:
Senior, C
Loveday, C
Citation: C. Senior et C. Loveday, A pilot investigation into the neuroendocrine correlates of personality inthe workplace, PERC MOT SK, 87(3), 1998, pp. 794-794
Risultati:
1-25
|